| Serial Number | 97379421 |
| Word Mark | LUMABRIDGE |
| Filing Date | Monday, April 25, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 22, 2023 |
| Registration Number | 7147121 |
| Registration Date | Tuesday, August 22, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 25, 2022 |
| Goods and Services | Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Providing business intelligence services in the fields of medical devices and pharmaceuticals |
| Goods and Services | Regulatory compliance consulting in the field of medical products; Regulatory compliance consulting in the field of prescription drug sampling |
| Goods and Services | Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the fields of oncology, immunology, military medicine, emergency medicine, critical care, regenerative medicine, infectious disease; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Medical research; Scientific research and development; Biomedical research services; Providing information about medical and scientific research; Research and development of vaccines and medicines; Consulting services in the fields of biotechnology and pharmaceutical research and development; Pharmaceutical research and development; Pharmaceutical drug development services; Technical research in the field of pharmaceutical studies; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 29, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | Tuesday, August 23, 2022 |
| First Use In Commerce Date | Tuesday, August 23, 2022 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 21, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, August 23, 2022 |
| First Use In Commerce Date | Tuesday, August 23, 2022 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 29, 2022 |
| Primary Code | 045 |
| First Use Anywhere Date | Tuesday, August 23, 2022 |
| First Use In Commerce Date | Tuesday, August 23, 2022 |
| Party Name | LUMABRIDGE, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | SAN ANTONIO, TX 78205 |
| Party Name | LUMABRIDGE, LLC |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | SAN ANTONIO, TX 78205 |
| Party Name | Clinical Research Insight, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | San Antonio, TX 78205 |
| Party Name | Clinical Research Insight, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | San Antonio, TX 78205 |
| Event Date | Event Description |
| Tuesday, August 22, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 22, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 18, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Monday, July 17, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, June 20, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, May 25, 2023 | USE AMENDMENT FILED |
| Tuesday, June 20, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, May 25, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, December 28, 2022 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, December 20, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 25, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 25, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 5, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, September 21, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 21, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, September 21, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, September 21, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, September 21, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, August 19, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, August 19, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, August 19, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, August 19, 2022 | ASSIGNED TO EXAMINER |
| Friday, April 29, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 28, 2022 | NEW APPLICATION ENTERED |